Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Drug Therapy, Combination28
Hydroxychloroquine (therapeutic use)61
Drug Therapy, Combination Sauf Hydroxychloroquine (therapeutic use)" 15
Hydroxychloroquine (therapeutic use) Sauf Drug Therapy, Combination" 48
Drug Therapy, Combination Et Hydroxychloroquine (therapeutic use) 13
Drug Therapy, Combination Ou Hydroxychloroquine (therapeutic use) 76
Corpus6435
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000E65 Águeda Prior-Espa Ol [Espagne] ; Melania Martínez-Morillo [Espagne] ; Anne Riveros-Frutos [Espagne] ; Alejandro Olivé [Espagne][Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
001513 Petros Efthimiou ; Manil Kukar ; Alissa Hersh [États-Unis]Rituximab and lupus interstitial lung disease: friend or foe?
001833 Kenia Rodrigues ; Fabricio S. Neves ; Karin B. L. Stoeterau ; Gláucio R. Werner Castro ; Luiz F. Nobre [Brésil] ; Adriana F. Zimmermann ; Ivânio A. PereiraPulmonary amyloidosis in Sjögren’s syndrome: a rare diagnosis for nodular lung lesions
001E36 Haneen Adel Al-Raqum [Koweït] ; Sukhbir Singh Uppal [Koweït] ; Moudi Al-Mutairy [Koweït] ; Rakesh Kumari [Koweït]Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti
002036 Ahmed S. Samad [États-Unis] ; Carol B. LindsleyTreatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
002156 M L Kingma [Pays-Bas] ; J H J M. Van Krieken ; J J E M. De Nef ; I T Merth[Persistent tachypnea in infants: possibly due to interstitial pneumonitis].
002717 N G Singer [États-Unis] ; W J MccuneUpdate on immunosuppressive therapy.
003060 E. Kerem [Canada] ; L. Bentur [Canada] ; S. England [Canada] ; J. Reisman [Canada] ; H. O'Brodovich [Canada] ; A. C. Bryan [Canada] ; H. Levison [Canada]Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis
003362 M. Csuka ; G F Carrera ; D J MccartyTreatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.
003426 Carin E. Dugowson ; Bruce C. GillilandManagement of rheumatoid arthritis
004013 Y. Uziel [Israël] ; B. Hen ; M. Cordoba ; B. WolachLymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis.
004015 J. Gordon [États-Unis] ; U. Udeh ; K. Doobay ; C. Magro ; H. Wildman ; M. Davids ; J N Mersten ; W-T Huang ; S. Lyman ; M K Crow ; R F SpieraImatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.
004019 Efstathios E. Detorakis [Grèce] ; Eleftherios Magkanas [Grèce] ; Ismini Lasithiotaki [Grèce] ; Prodromos Sidiropoulos [Grèce] ; Dimitrios T. Boumpas [Grèce] ; Nicholas Gourtsoyiannis [Grèce] ; Katerina Antoniou [Grèce] ; Maria Raissaki [Grèce]Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021